Specialist Pharmacovigilance Training London
One of the most experienced pharmacovigilance and pharmacoepidemiology experts in the world.
Professor Saad Shakir
Global Expert in Pharmacovigilance & Pharmacoepidemiology
★★★★★
“Collaborating with Professor Saad Shakir at Adroit Vigilance has significantly benefited our organisation. His pharmacovigilance and pharmacoepidemiology expertise deepens our drug safety understanding and fosters team adaptability. His guidance enhances patient outcomes and ensures proactive industry responses. We value his impactful commitment to excellence.”
– Dr. Edmund Burke
Pharmacovigilance Training London
Pharmacovigilance Training London
Pharmacovigilance Training London
Professor Saad Shakir is a highly regarded pharmacoepidemiology and drug safety expert, internationally recognised for his leadership in pharmacovigilance, pharmacoepidemiology, and regulatory governance. He delivers specialist consultancy and pharmacovigilance training in London, supporting pharmaceutical companies, regulatory authorities, and global healthcare organisations across the UK and internationally. His distinguished career includes senior roles within the UK Regulatory Authority, GSK, and RPR, followed by his tenure as Director of the Drug Safety Research Unit in Southampton. In June 2025, he established his independent consultancy, providing expert drug safety advisory services and advanced pharmacovigilance training worldwide.
Through pharmacovigilance training in London, Professor Shakir advises on complex and high-risk drug safety matters, including product withdrawals, risk management and mitigation strategies, regulatory submissions, and large-scale pharmacovigilance programmes. He combines deep clinical expertise with advanced epidemiological methods to support PASS studies, risk minimisation plans, real-world evidence generation, and post-authorisation safety strategies, underpinned by comprehensive knowledge of UK, EU, and US regulatory frameworks.
He offers strategic oversight for safety submissions and regulatory responses, working closely with multinational pharmaceutical organisations as well as mid-sized and emerging life sciences companies operating in the UK and global markets. His experience also includes extensive collaboration with regulatory bodies and international institutions, where he has served as Chair or member of Safety Advisory Boards and Data Safety Monitoring Committees.
A widely published authority in the field, Professor Shakir has authored numerous peer-reviewed journal articles, book chapters, and conference abstracts covering pharmacovigilance, pharmacoepidemiology, and risk management. He also serves on editorial boards for leading journals, including Drug Safety and Pharmacoepidemiology and Drug Safety.
Dedicated to advancing global standards in drug safety, Professor Shakir delivers pharmacovigilance training in London, across the UK, and internationally. He is a regular keynote speaker at scientific and regulatory conferences, promoting best practice, regulatory compliance, and excellence in pharmacovigilance and pharmacoepidemiological research.
Professor Saad Shakir
MB ChB, LRCP&S FRCP FISPE MRCGP
Global Drug Safety Consultancy & Pharmacoepidemiology Consultant UK
Pharmacovigilance Training London
Saad Shakir is a highly respected pharmacoepidemiology and drug safety specialist, internationally recognised for his expertise in pharmacovigilance, pharmacoepidemiology, and regulatory drug safety across the UK, the United States, Europe, and global markets. He delivers specialist consultancy services and pharmacovigilance training in London, supporting organisations and regulatory stakeholders in achieving regulatory compliance, operational excellence, and best practice in drug safety.
With a distinguished career spanning senior leadership roles within the UK Regulatory Authority, GSK, and RPR, Saad later served as Director of the Drug Safety Research Unit in Southampton. His background reflects extensive experience across regulatory, commercial, and academic settings, with deep knowledge of UK, US, EU, and international regulatory frameworks.
In June 2025, he established his independent consultancy, Adroit Vigilance, providing expert pharmacovigilance advisory services, advanced professional training programmes, and strategic drug safety support. Through pharmacovigilance training in London, he works closely with organisations to strengthen pharmacovigilance systems, enhance regulatory compliance, and implement robust risk management strategies aligned with UK, EU, US, and global regulatory requirements.
Our Services
Drug safety services are essential to safeguarding patient wellbeing and maintaining trust in healthcare systems. Pharmacovigilance training in London supports organisations in developing the expertise required to monitor and evaluate adverse drug reactions, carry out robust risk assessments, and implement effective risk minimisation strategies in line with UK, EU, US, and international regulatory requirements.
Through the systematic collection, analysis, and interpretation of safety data, pharmacovigilance training in London enables the early identification of medicine-related risks, supporting evidence-based clinical decision-making and timely regulatory action. High-quality training equips healthcare and life sciences professionals with the practical knowledge needed to ensure the safe and appropriate use of medicines, reduce the risk of misuse, and uphold best practice standards in pharmacovigilance.
By placing patient safety, regulatory compliance, and therapeutic effectiveness at the core of drug safety strategy, pharmacovigilance training in London contributes to improved patient outcomes and helps reinforce long-term confidence in pharmaceutical products and healthcare providers.
Consultancy & Advice
We provide expert consultancy and advice in the fields of pharmacovigilance and pharmacoepidemiology. Our services include:
Risk Management: We handle risk management and risk minimization, including monitoring its effectiveness.
Safety Studies: We conduct Real World Studies and PASS (Post-Authorisation Safety Studies).
Benefit/Risk Evaluation: We perform thorough benefit/risk evaluations.
Regulatory Submissions: We assist with pharmacovigilance submissions and responses to regulatory authorities.
ADR Assessment: We provide assessment of single and clusters of Adverse Drug Reaction (ADR) reports.
Specialised Boards: Saad is experienced in working with Data Safety Management Boards and Advisory Committees.
Medicolegal Work: We also undertake medicolegal work.
Training & Education
Our courses deliver the essential knowledge and practical skills required for the safe handling, management, and administration of medicines. Through Pharmacovigilance Training UK, participants complete structured modules covering drug classifications, adverse effects, and best practice guidance for storage, handling, and disposal. Learning is supported by expert-led sessions, real-world case studies, and practical exercises, enabling attendees to identify, assess, and mitigate medication-related risks across a range of settings. Strong emphasis is placed on regulatory compliance, ethical responsibility, and patient safety, equipping healthcare professionals, pharmacists, and medicine management teams with the confidence to maintain the highest standards of care.
We are committed to training and education on a wide range of topics in pharmacovigilance and pharmacoepidemiology. Our training is delivered through various formats:
Delivery Methods: Training can be delivered online, hybrid, or face-to-face.
Training Options: We offer in-house training, specific training courses, and conferences.
Collaborative Projects
As a leading expert in pharmacoepidemiology, we actively participate in international collaborative projects aimed at advancing pharmacovigilance standards and enhancing patient safety. Through pharmacovigilance training in London, these initiatives support innovation in drug safety and pharmacoepidemiology, promote regulatory best practice, and contribute to improved patient outcomes across the UK, Europe, and global healthcare markets.
For general enquiries about AdroitVigilance and our services or courses, please fill out the form provided.
If you would like to engage Professor Saad Shakir, a leading pharmacoepidemiology consultant, for consultancy support, speaking engagements, or pharmacovigilance training in London, please complete the enquiry form. For urgent matters, Professor Shakir can be contacted directly using the details below; however, response times may vary due to international professional commitments.
To ensure the most effective support, please provide a clear outline of your requirements and objectives. Alternatively, you may contact us by email or telephone to arrange a consultation or a bespoke training programme with an experienced pharmacoepidemiology consultant.